Journal My Health

Directions Website

Journal My Health The Journal My Health app helps people with chronic conditions tell their health stories to their health providers, for better health outcomes.

Available on iOS and Android.

The data gap that matters most in chronic-condition tracking isn't missing days overall — it's missing the worst days sp...
10/14/2026

The data gap that matters most in chronic-condition tracking isn't missing days overall — it's missing the worst days specifically.

People are most likely to skip logging exactly when they're flaring, which means the data set silently excludes the moments that would be most clinically and personally useful. Tools that lower the bar to a single tap — no writing required — see meaningfully better completion on high-symptom days.

That's a detail worth asking about if you're comparing tracking tools for a benefits program.

Let's talk if you want to dig into what "low-friction on bad days" actually looks like in practice.

The wellness benefits that get used aren't the ones with the most features — they're the ones with the lowest friction.A...
10/07/2026

The wellness benefits that get used aren't the ones with the most features — they're the ones with the lowest friction.

A 30-second daily log will always outperform a comprehensive but cumbersome tool, because adherence beats sophistication when it comes to real-world data collection.

This is a design principle worth pressure-testing in any chronic-condition or wellness benefit you're considering: how much effort does day 1 actually require, and does that effort stay low through week 4?

Engagement drop-off in the first two weeks is the single biggest threat to any self-tracked wellness benefit — and it's ...
09/30/2026

Engagement drop-off in the first two weeks is the single biggest threat to any self-tracked wellness benefit — and it's rarely about the tool.

It's about the lag between effort and payoff. Employees start logging symptoms and don't see anything meaningful for a week or more, so they assume it isn't working and stop. The organizations that get the most value from tools like Journal My Health are the ones that set expectations upfront: this is a 2-3 week investment before the insight shows up, not a same-day dashboard.

If you're evaluating a self-tracking benefit, ask the vendor how they handle the early drop-off window. It matters more than the feature list.

Engagement drop-off in the first two weeks is the single biggest threat to any self-tracked wellness benefit — and it's ...
09/16/2026

Engagement drop-off in the first two weeks is the single biggest threat to any self-tracked wellness benefit — and it's rarely about the tool.

It's about the lag between effort and payoff. Employees start logging symptoms and don't see anything meaningful for a week or more, so they assume it isn't working and stop. The organizations that get the most value from tools like Journal My Health are the ones that set expectations upfront: this is a 2-3 week investment before the insight shows up, not a same-day dashboard.

If you're evaluating a self-tracking benefit, ask the vendor how they handle the early drop-off window. It matters more than the feature list.

A month of pattern-insight data can change more than an individual conversation — it can change how an organization thin...
09/02/2026

A month of pattern-insight data can change more than an individual conversation — it can change how an organization thinks about chronic-condition support.

Over the past few weeks, we've talked about the overlap between autoimmune conditions and menopause, why real-world tracking data matters, and how it helps women walk into medical appointments prepared instead of dismissed. That same data, aggregated and anonymized, is exactly the kind of signal employers and health plans need to design better, earlier support.

Journal My Health is currently exploring partnerships with organizations who want to be ahead of this curve.

If that's you, let's set up time to talk.

Real-world symptom data is one of the most underused inputs in chronic-condition benefits design.Most benefits programs ...
08/26/2026

Real-world symptom data is one of the most underused inputs in chronic-condition benefits design.

Most benefits programs are built around claims data — after the fact, after the cost has already landed. Journal My Health takes a different approach: helping individuals build a day-to-day picture of their own patterns, in plain, non-clinical language they can act on immediately.

For employers and health plans evaluating where to invest in chronic-condition support, that's a signal worth paying attention to — a low-cost, low-friction way to help employees self-advocate before symptoms become a bigger (and more expensive) problem.

If you're rethinking what "chronic condition support" looks like for your team, I'd love to compare notes.

What if the simplest benefit you could offer women navigating menopause and autoimmune symptoms wasn't a new specialist ...
08/19/2026

What if the simplest benefit you could offer women navigating menopause and autoimmune symptoms wasn't a new specialist — it was a way to help them advocate for themselves?

Journal My Health isn't a clinical tool, and it's not trying to replace care. It's a wellness platform that helps women build a clear, pattern-based picture of their own health — the kind of specific, day-to-day insight that makes existing medical appointments more productive, faster.

For organizations exploring low-cost, high-impact additions to their benefits mix, this is worth a look: something employees can start using immediately, with no clinical overhead, that directly supports better conversations with the providers they already see.

Open to a short conversation about what a pilot could look like for your team?
Happy to share more.

Every HR leader is thinking about chronic condition costs. Almost none are thinking about the autoimmune-menopause overl...
08/12/2026

Every HR leader is thinking about chronic condition costs. Almost none are thinking about the autoimmune-menopause overlap.

Millions of women in the workforce are navigating both at once — and the symptom overlap makes it harder to identify, harder to manage, and easier to dismiss as "just stress." The result: absenteeism, reduced productivity, and employees who don't have the language to advocate for what they need.

At Journal My Health, we're building tools that help women identify their own patterns — turning "I don't feel right" into something specific enough to act on. That's not just better for the individual. It's a smarter, lower-cost starting point for any organization thinking about chronic-condition support.

Curious what this could look like as part of a benefits conversation? Let's talk.

A new analysis presented at The Menopause Society's 2025 Annual Meeting looked at nearly 1.8 million postmenopausal wome...
08/05/2026

A new analysis presented at The Menopause Society's 2025 Annual Meeting looked at nearly 1.8 million postmenopausal women — and found hormone therapy use was linked to a higher incidence of autoimmune disease.

That's a big, unsettling headline for anyone already navigating an autoimmune condition through menopause.

But the study's own lead author, Dr. Xuezhi (Daniel) Jiang of Drexel University College of Medicine, was careful to add context: the actual increase in absolute risk is relatively small and varies by condition, and because it's a retrospective database study, more research is needed before drawing firm conclusions. He was clear that hormone therapy remains a safe and important option for many women when used appropriately.

The throughline from both Dr. Jiang and The Menopause Society's medical director, Dr. Stephanie Faubion: this needs to be individualized. Not a blanket yes or no — a decision based on each woman's own body.

The problem is, most women walk into that conversation with nothing individual to bring. No data on how their body actually responds to sleep, stress, weather, or flares before they even start a new treatment. Just a headline, a worry, and a 15-minute appointment.

That's the gap Journal My Health exists to close. Daily tracking turns "I'm not sure how I'll react" into a real pattern — something specific enough to actually inform an individualized decision, instead of guessing from a population-level study.

Evidence, not guesswork. That's what individualized care requires.

07/29/2026

Apple just put a perimenopause flag inside the default Health app. That's a big deal — not because of what it does, but because of what it signals.

When a platform with roughly a billion active Health app users decides cycle-pattern detection for perimenopause is worth building, it's confirming something the women's health field has been saying for years: this transition has been chronically under-instrumented, and demand for better tools is enormous. Add Midi Health's $100M raise at a $1B valuation this year, and the market signal is unmistakable.

Here's where it gets interesting for us. Apple's feature does what a great consumer platform should do at scale: it notices a pattern shift and nudges you to pay attention. What it isn't built to do — and isn't trying to do — is connect that shift to the layered picture underneath it: autoimmune flares, sleep architecture, weather sensitivity, medication response, all moving together during the transition.

That's the exact population Journal My Health was built for. Apple can tell a woman she may be entering perimenopause. We're building the tools to help her and her clinician understand what that intersection is actually doing to her body — with data detailed enough to inform real treatment decisions, not just awareness.

Big Tech validating the category is a gift for everyone building real infrastructure underneath it. We intend to use it.

Address

Philadelphia, PA

Website

Alerts

Be the first to know and let us send you an email when Journal My Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category